174 related articles for article (PubMed ID: 29113771)
1. Rate and Extent of Pelvic Lymph Node Dissection in the US Prostate Cancer Patients Treated With Radical Prostatectomy.
Nocera L; Sood A; Dalela D; Gild P; Rogers CG; Peabody JO; Montorsi F; Menon M; Briganti A; Abdollah F
Clin Genitourin Cancer; 2018 Apr; 16(2):e451-e467. PubMed ID: 29113771
[TBL] [Abstract][Full Text] [Related]
2. Indication for and extension of pelvic lymph node dissection during robot-assisted radical prostatectomy: an analysis of five European institutions.
Suardi N; Larcher A; Haese A; Ficarra V; Govorov A; Buffi NM; Walz J; Rocco B; Borghesi M; Steuber T; Pini G; Briganti A; Mottrie AM; Guazzoni G; Montorsi F; Pushkar D; Van Der Poel H;
Eur Urol; 2014 Oct; 66(4):635-43. PubMed ID: 24411992
[TBL] [Abstract][Full Text] [Related]
3. Surgeon-led prostate cancer lymph node staging: pathological outcomes stratified by robot-assisted dissection templates and patient selection.
Altok M; Babaian K; Achim MF; Achim GC; Troncoso P; Matin SF; Chapin BF; Davis JW
BJU Int; 2018 Jul; 122(1):66-75. PubMed ID: 29446205
[TBL] [Abstract][Full Text] [Related]
4. The impact of robot-assisted radical prostatectomy on the use and extent of pelvic lymph node dissection in the "post-dissemination" period.
Gandaglia G; Trinh QD; Hu JC; Schiffmann J; Becker A; Roghmann F; Popa I; Tian Z; Perrotte P; Montorsi F; Briganti A; Karakiewicz PI; Sun M; Abdollah F
Eur J Surg Oncol; 2014 Sep; 40(9):1080-6. PubMed ID: 24411705
[TBL] [Abstract][Full Text] [Related]
5. Extended pelvic lymph node dissection in prostate cancer: a 20-year audit in a single center.
Abdollah F; Suardi N; Gallina A; Bianchi M; Tutolo M; Passoni N; Fossati N; Sun M; dell'Oglio P; Salonia A; Karakiewicz PI; Rigatti P; Montorsi F; Briganti A
Ann Oncol; 2013 Jun; 24(6):1459-66. PubMed ID: 23508825
[TBL] [Abstract][Full Text] [Related]
6. Adherence to pelvic lymph node dissection recommendations according to the National Comprehensive Cancer Network pelvic lymph node dissection guideline and the D'Amico lymph node invasion risk stratification.
Leyh-Bannurah SR; Budäus L; Zaffuto E; Pompe RS; Bandini M; Briganti A; Montorsi F; Schiffmann J; Shariat SF; Fisch M; Chun F; Huland H; Graefen M; Karakiewicz PI
Urol Oncol; 2018 Feb; 36(2):81.e17-81.e24. PubMed ID: 29248430
[TBL] [Abstract][Full Text] [Related]
7. Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasion.
Preisser F; Bandini M; Marchioni M; Nazzani S; Tian Z; Pompe RS; Fossati N; Briganti A; Saad F; Shariat SF; Heinzer H; Huland H; Graefen M; Tilki D; Karakiewicz PI
Prostate; 2018 May; 78(6):469-475. PubMed ID: 29460290
[TBL] [Abstract][Full Text] [Related]
8. Utilization of Pelvic Lymph Node Dissection for Patients With Low-Risk Prostate Cancer Treated With Robot-Assisted Radical Prostatectomy.
Modi PK; Bock M; Kim S; Singer EA; Parikh RR
Clin Genitourin Cancer; 2017 Dec; 15(6):e1001-e1006. PubMed ID: 28558990
[TBL] [Abstract][Full Text] [Related]
9. Pelvic lymph node dissection in prostate cancer.
Briganti A; Blute ML; Eastham JH; Graefen M; Heidenreich A; Karnes JR; Montorsi F; Studer UE
Eur Urol; 2009 Jun; 55(6):1251-65. PubMed ID: 19297079
[TBL] [Abstract][Full Text] [Related]
10. Utilization and impact of surgical technique on the performance of pelvic lymph node dissection at radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital database.
McGinley KF; Sun X; Howard LE; Aronson WJ; Terris MK; Kane CJ; Amling CL; Cooperberg MR; Freedland SJ
Int J Urol; 2016 Mar; 23(3):241-6. PubMed ID: 26667212
[TBL] [Abstract][Full Text] [Related]
11. Outcomes after radical prostatectomy for patients with clinical stages T1-T2 prostate cancer with pathologically positive lymph nodes in the prostate-specific antigen era.
Dorin RP; Lieskovsky G; Fairey AS; Cai J; Daneshmand S
Urol Oncol; 2013 Nov; 31(8):1441-7. PubMed ID: 22516714
[TBL] [Abstract][Full Text] [Related]
12. Utilization of pelvic lymph node dissection in patients undergoing robot-assisted radical prostatectomy in India versus the United States - A Vattikuti Collective Quality Initiative database analysis.
Abdollah F; Arora S; Jindal T; Gild P; Sood A; Yuvaraja TB; Ahlawat RK; Gupta NP; Bhandari M; Menon M
Indian J Cancer; 2017; 54(2):421-425. PubMed ID: 29469070
[TBL] [Abstract][Full Text] [Related]
13. Pelvic lymph node dissection and its extent on survival benefit in prostate cancer patients with a risk of lymph node invasion >5%: a propensity score matching analysis from SEER database.
Chen J; Wang Z; Zhao J; Zhu S; Sun G; Liu J; Zhang H; Zhang X; Shen P; Shi M; Zeng H
Sci Rep; 2019 Nov; 9(1):17985. PubMed ID: 31784574
[TBL] [Abstract][Full Text] [Related]
14. The impact of robotic surgery on pelvic lymph node dissection during radical prostatectomy for localized prostate cancer: the Brown University early robotic experience.
Yates J; Haleblian G; Stein B; Miller B; Renzulli J; Pareek G
Can J Urol; 2009 Oct; 16(5):4842-6. PubMed ID: 19796462
[TBL] [Abstract][Full Text] [Related]
15. Reconsidering the role of pelvic lymph node dissection with radical prostatectomy for prostate cancer in an era of improving radiological staging techniques.
Yaxley JW; Dagher J; Delahunt B; Egevad L; Srigley J; Samaratunga H
World J Urol; 2018 Jan; 36(1):15-20. PubMed ID: 29116393
[TBL] [Abstract][Full Text] [Related]
16. Increasing rate of lymph node invasion in patients with prostate cancer treated with radical prostatectomy and lymph node dissection.
Preisser F; Nazzani S; Bandini M; Marchioni M; Tian Z; Montorsi F; Saad F; Briganti A; Steuber T; Budäus L; Huland H; Graefen M; Tilki D; Karakiewicz PI
Urol Oncol; 2018 Aug; 36(8):365.e1-365.e7. PubMed ID: 29887241
[TBL] [Abstract][Full Text] [Related]
17. Adherence of the indication to European Association of Urology guideline recommended pelvic lymph node dissection at a high-volume center: Differences between open and robot-assisted radical prostatectomy.
Schiffmann J; Haese A; Leyh-Bannurah SR; Salomon G; Steuber T; Schlomm T; Boehm K; Beyer B; Larcher A; Michl U; Heinzer H; Huland H; Graefen M; Karakiewicz PI
Eur J Surg Oncol; 2015 Nov; 41(11):1547-53. PubMed ID: 26117216
[TBL] [Abstract][Full Text] [Related]
18. Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy.
Heidenreich A; Ohlmann CH; Polyakov S
Eur Urol; 2007 Jul; 52(1):29-37. PubMed ID: 17448592
[TBL] [Abstract][Full Text] [Related]
19. Nodal counts during pelvic lymph node dissection for prostate cancer: an objective indicator of quality under the influence of very subjective factors.
Mazzola C; Savage C; Ahallal Y; Reuter VE; Eastham JA; Scardino PT; Guillonneau B; Touijer KA
BJU Int; 2012 May; 109(9):1323-8. PubMed ID: 21992661
[TBL] [Abstract][Full Text] [Related]
20. Pathologic nodal staging scores in patients treated with radical prostatectomy: a postoperative decision tool.
Kluth LA; Abdollah F; Xylinas E; Rieken M; Fajkovic H; Sun M; Karakiewicz PI; Seitz C; Schramek P; Herman MP; Becker A; Loidl W; Pummer K; Nonis A; Lee RK; Lotan Y; Scherr DS; Seiler D; Chun FK; Graefen M; Tewari A; Gönen M; Montorsi F; Shariat SF; Briganti A
Eur Urol; 2014 Sep; 66(3):439-46. PubMed ID: 23850255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
